Editas Medicine, Inc. (EDIT)
Since May 05, 2021, Editas Medicine, Inc. (EDIT) has reported earnings 21 times. On average the shares move ±10.22% post-earnings, with a positive reaction 76.2% of the time. Its largest post-earnings gain was +34.5% (Aug 12, 2025) and its largest decline was -13.17% (Mar 05, 2025). The next earnings report is predicted for 2026-08-10 (approximate).
Earnings reactions
How EDIT moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±10.22%
Positive %
76.2%
Negative %
23.8%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 05, 2026 | ☀ PRE | +0.83% | open_in_new |
| Mar 09, 2026 | ☀ PRE | +16% | open_in_new |
| Nov 10, 2025 | ☀ PRE | +2.02% | open_in_new |
| Aug 12, 2025 | ☽ POST | +34.5% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±10.22%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260721 | open_in_new SEC.gov |
| 4 | 20260622 | open_in_new SEC.gov |
| 4 | 20260622 | open_in_new SEC.gov |
| 4 | 20260622 | open_in_new SEC.gov |
| 4 | 20260622 | open_in_new SEC.gov |
| 4 | 20260622 | open_in_new SEC.gov |
| 8-K | 20260618 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
Frequently asked about EDIT earnings
When does Editas Medicine, Inc. report earnings next? expand_more
Editas Medicine, Inc. (EDIT)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does EDIT stock move after earnings? expand_more
Over 21 reports, EDIT has moved an average of ±10.22% the session after earnings, closing higher 76.2% of the time.
What was EDIT's biggest post-earnings move? expand_more
EDIT's largest post-earnings gain on record was +34.5% on Aug 12, 2025, and its largest decline was -13.17% on Mar 05, 2025.
Where can I find Editas Medicine, Inc.'s SEC filings? expand_more
All of Editas Medicine, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALICO, INC. (ALCO) earnings 2026-08-07
- ASCENT INDUSTRIES CO. (ACNT) earnings 2026-08-07
- Aclaris Therapeutics, Inc. (ACRS) earnings 2026-08-07
- ACV Auctions Inc. (ACVA) earnings 2026-08-07
- ADC Therapeutics SA (ADCT) earnings 2026-08-07
- ADMA BIOLOGICS, INC. (ADMA) earnings 2026-08-07
- Aeva Technologies, Inc. (AEVA) earnings 2026-08-07
- Agenus Inc. Common Stock (AGEN) earnings 2026-08-07